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Abstract
Background: Compound Muniziqi granule (MNZQ), a traditional Uighur medicinal preparation, comprises 13 species
of medicinal plants. MNZQ is traditionally used for regulating body immunity, modulating inflammation and pain,
detoxification, and inhibiting tumor growth. This study aims to scientifically evaluate the anti-inflammatory and
analgesic activities of MNZQ, support its clinical use and further research with scientific evidence.
Methods: The analgesic activity of MNZQ was evaluated using hot plate test and acetic acid-induced abdominal
writhing test. Acute inflammation was evaluated using xylene-induced ear edema and carrageenan-induced paw
edema models, while chronic inflammation was evaluated using cotton pellet-induced granuloma model.
Results: MNZQ exerted analgesic activities with a significant dose-dependent increase in latency in the hot plate test.
The percentage inhibition suggested that MNZQ exhibited analgesic activities in the central nervous system.
Meanwhile, MNZQ at 0.8, 2.4, and 7.2 g/kg strongly inhibited the acetic acid-induced writhing response by
25.22 % (p < 0.01), 44.60 % (p < 0.001), and 49.41 % (p < 0.001), respectively. MNZQ also exerted analgesic
activities in the peripheral nervous system. Moreover, MNZQ was demonstrated a significant anti-inflammatory
effect against xylene-induced edema in a dose-dependent manner. The percentage inhibition was 22.24 % (p < 0.01) at
the highest dosage of 7.2 g/kg. MNZQ at 1.62 and 4.86 g/kg significantly reduced carrageenan-induced rat hind paw
edema by 82.43 % and 84.32 % (p < 0.001), respectively, 1 h after injecting carrageenan, and the inhibitory effect lasted
for 5 h. MNZQ also exerted a significant anti-inflammatory effect against cotton pellet-induced granuloma formation.
MNZQ at 1.62 and 4.86 g/kg could inhibit granuloma formation by 17.07 % and 17.60 %, respectively, whereas the
percentage inhibition of diclofenac was 33.12 %.
Conclusions: The results obtained suggest that MNZQ possesses potential anti-inflammatory and analgesic activities.
This study provides a scientific basis for the use of MNZQ in alleviating pain and treating inflammatory disorders.
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Background
Inflammation has become the major focus of global scien-
tific research in all human and animal diseases [1]. Many
physical, chemical, and biological stimuli or some of their
combinations can cause nonspecific inflammation in in-
jured tissues. Bacterial and viral infections can cause many
signaling molecules, macrophages, monocytes, and neu-
trophils to produce inflammatory mediators such as nitric
oxide, prostaglandin, and tumor necrosis factor (TNF-α)
[2]. Nonsteroidal anti-inflammatory drugs (NSAIDs) are
widely used inflammation treatments worldwide [3, 4].
However, the applications of NSAIDs for gastric ulcer, kid-
ney damage, bronchitis, and cardiovascular diseases are
limited by their side effects [5]. Therefore, developing
anti-inflammatory drugs from traditional medicines with
few side effects is imperative [6].
Compound Muniziqi granule (MNZQ), a popular trad-
itional Uighur medicine (TUM), is recorded in the Ministry
of Health of the People’s Republic of China Pharmaceutical
Standards–Uighur Medicine [7]. As described in Table 1,
MNZQ comprises 13 species of medicinal plants, in-
cluding seeds of Peganum harmala, Cichorium intybus,
Dracocephalum moldavica, Ocimum basilicum, Althaea
rosea, and Nigella glandulifera; fruits of Pimpinella
anisum; roots of Apium graveolens, Glycyrrhiza uralensis
and Cichorium intybus; Cortex of Foeniculum vulgare;
and herbs of Matricaria chamomilla and Cymbopogon
caesius. According to TUM, excess or deficiency in one or
more of the four body fluids, namely, Khan (blood),
phlegm, Sapra (yellow bile), and Savda (black bile), can
influence human metabolism and cause diseases [8, 9]. As
a maturative agent of the four abnormal body fluids,
MNZQ can help these fluids recover from imbalances and
treat diseases. In clinical settings, MNZQ can effectively
regulate hormone synthesis and metabolism, and treat
endocrine disorder-induced acne, chloasma, dysmenor-
rhea, menopausal syndrome, and inflammation of the skin
or female genitalia [10].
Most of constituents of medicinal plants in MNZQ have
potential anti-inflammatory activities. P. harmala exerts
some pharmacological effects, including antibacterial, anti-
inflammatory, analgesic, antipruritic, parasite-resistant, and
antirheumatic effects [11]. For centuries, M. chamomilla
and Glycyrrhiza have been widely used to eliminate inflam-
mation and to treat various inflammatory disorders such as
eczema, ulcers, gout, neuralgia, and rheumatic pains [12].
Glycyrrhiza species have also been used worldwide to treat
injury or swelling. Meanwhile, D. moldavica, N. glanduli-
fera, C. intybus, and O. basilicum exert anti-inflammatory
effects [13]. However, it is yet to be determined whether
MNZQ maintains strong anti-inflammatory and analgesic
activities. Laboratory-based ethnopharmacological investi-
gations of MNZQ in a broad context may impart complete
understanding of TUM practice and use in China.
In recent years, few studies have shown that MNZQ can
strongly inhibit dinitrofluorobenzene-induced allergic con-
tact dermatitis and chloasma [14, 15]. MNZQ treats various
pelvic inflammatory diseases possibly by regulating the ex-
pression of TNF-α, IL-1β, and IL-10 [16]. Tamoxifen citrate
tablets combined with MNZQ alleviate the pain caused by
mammary gland hyperplasia [17]. However, there is insuffi-
cient data to support the anti-inflammatory and analgesic
activities of MNZQ. The aim of this study is to provide sci-
entific evidence for the ethnopharmacological use of MNZQ
in alleviating pain and treating inflammatory disorders.
Methods
Reagents and materials
MNZQ was provided by Xinjiang Uighur Pharmaceutical
Co., Ltd. (Xinjiang, China; Batch No. 1212522). HPLC
Table 1 Information of components in Compound Muniziqi granules (MNZQ)
Botanical name Herbal name Part used Chinese name Ratio Voucher no
Peganum harmala L. Pegani semen Seed Luo-Tuo-Peng-Zi 2 Y120514
Pimpinella anisum L. Pimpinellae anisi fructus Fruit Hui-Qin-Guo 2 Y130142
Foeniculum vulgare Mill. Foeniculi cortex Root bark Hui-Xiang-Gen-Pi 2 Y130408
Dracocephalum moldavica L. Dracocephali semen Seed Xiang-Qing-Lan-Zi 1 Y120923
Ocimum basilicum L. Ocimi basilici semen Seed Luo-Le-Zi 1 Y110836
Althaea rosea (L.) Gavan. Althaea semen Seed Shu-Kui-Zi 1 Y130303
Nigella glandulifera Freyn et Sint. Nigellae semen Seed Hei-Zhong-Cao-Zi 1 Y120119
Apium graveolens L. Apii radix Root Qin-Cai-Gen 1 Y130312
Cichorium intybus L. Cichorii radix Root Ju-Ju-Gen 1 Y130212
Cichorium intybus L. Cichorii semen Seed Ju-Ju-Zi 1 Y120812
Glycyrrhiza uralensis Fisch. Glycyrrhizae radix Et Rgizoma Root Gan-Cao 1 Y130141
Matricaria chamomilla L. Chamomillae herba Herba Yang-Gan-Ju 1 Y120927
Cymbopogon caesius (Ness) Stapf. Cymboponis herba Herba Xiang-Mao 1 Y121112
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grade acetonitrile was purchased from Fisher Scientific
(Fair Lawn, NJ, USA). Ultrapure water was obtained from
a Milli-Q water purification system (Billipore, MA, USA).
Acetic salicylic acid (ASA) was purchased from Huayin
City Jinqiancheng Pharmaceutical Co., Ltd. (Shanxi,
China; Batch No. A1111002). Diclofenac sodium and
carrageenan were purchased from Sigma-Aldrich Co. (St.
Louis, MO, USA). Xylene and acetic acid were purchased
from Sinopharm Chemical Reagent Co., Ltd. (Shanghai,
China). The standard reference compounds of chlorogenic
acid, caffeic acid, ferulic acid, liquiritin, harmaline, har-
mine, apigenin 7-O-glucoside, and isoliquiritin were
purchased from Shanghai R&D Center for Standardization
of Chinese Medicines. All other chemicals used were of
analytical grade.
Experimental animals
All experimental animals, including male and female
Kunming (KM) mice weighing 20–25 g and male adult
Wistar rats weighing 180–200 g (Certificate No. SYXK,
Shanghai, 2009–0069), were obtained from SLAC Labora-
tory Animal Co., Ltd. (Shanghai, China) and housed by
the Animal Center of Shanghai University of Traditional
Chinese Medicine. The rats were housed in an air-
conditioned room with a temperature of 22–24 °C and a
relative humidity of 60 %–65 % with a 12 h dark–light
cycle (light on from 7:00 to 19:00). All animals were pro-
vided with standard pellet diet and water spontaneously.
The animals were acclimatized to the facilities for 7 days
and then allowed to fast with free access to water 12 h
before the experiments. The animal studies were con-
ducted in accordance with the Institute’s Guide for the
Care and Use of Laboratory Animals and were approved
by the Ethical Committee of Shanghai University of
Traditional Chinese Medicine (Approval No. ACSHU-
2014-200, approved in 16 July, 2014).
High performance liquid chromatography (HPLC)
fingerprinting and quantitative determination
Instruments and chromatographic conditions
An HPLC system equipped with an Agilent 1260 series
(Agilent technologies, Waldbronn, Germany) LC system
was used. This LC System constituted a G1311B quater-
nary pump, a G1321B degasser, a G1367E automatic sam-
pler, a G1316A thermostated column compartment, and
G1315C diode array detection. All samples were separated
on a C18 chromatographic column (4.6 mm× 250 mm,
5 μm, Boston Lunna Clone, Boston Analytics, Inc., USA)
with a gradient system of acetonitrile (A) and ammonium
acetate buffer (B). The elution program is described in
Table 2. The flow rate was 1 mL/min, the injection volume
was 20 μL, and the column temperature was maintained
at 30 °C. The detection wavelength was set at 335 nm.
Ammonium acetate buffer was prepared by dissolving
3.4 g of ammonium acetate in 500 mL of pure water, and
glacial acetic acid (3 mL) was added to adjust pH to 4.5.
Standard preparation
The standard stock solutions of chlorogenic acid
(0.52 mg/mL), caffeic acid (0.54 mg/mL), ferulic acid
(0.54 mg/mL), liquiritin (0.52 mg/mL), harmaline
(1.04 mg/mL), harmine (0.82 mg/mL), apigenin 7-O-
glucoside (0.48 mg/mL), and isoliquiritin (0.50 mg/
mL) were prepared in methanol and stored at 4 °C.
Working solutions of these standard solutions were
prepared by dilution of the stock solution.
Sample preparation
A 15 g aliquot of MNZQ sample (Batch No. 1210481) was
completely dissolved in 20 mL of 0.05 M hydrochloric
acid solution and extracted three times with 40 mL of
ethyl acetate in a separatory funnel. The organic su-
pernatants were combined to evaporate to dryness.
The residue was dissolved in 2 mL of methanol, and
then the solution was filtered through a Millipore filter
(0.45 μm) to obtain the sample solution before injection
into LC system for analysis.
Fingerprinting and quantitative determination
Working solutions of standard solutions and sample solu-
tion were injected into LC system for analysis fingerprint-
ing of MNZQ, and the individual peak in fingerprint of
MNZQ was confirmed by comparing with reference stan-
dards. Further the content of each characteristic peak was
quantitatively determined by a validated method (no pub-
lished data).
Drug administration
MNZQ was dissolved in distilled water and administered
orally. The MNZQ dosage for animal was extrapolated
from the human daily dose of 18 g based on body
weight. On the basis of the equivalent dose rate conver-
sion for animal and human body surface areas, the mid-
dle dosages for mice and rats were 2.4 and 1.62 g/kg,
respectively. For three times the gradient of the middle
dose, the low dosages for mice and rats were 0.8 and
0.54 g/kg, and the high dosages were 7.2 and 4.86 g/kg,
respectively. The dose volume was 20 mL/kg for mice
Table 2 Gradient elution program for HPLC
Time (min) Flow (mL/min) % acetonitrile (A) % ammonium acetate
buffer, PH 4.5 (B)
0~5 1 5 95
5~25 1 18 82
25~30 1 18 82
30~45 1 32 68
45~60 1 70 30
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and 10 mL/kg for rats, respectively. During the period of
administration, rats were kept under regular observation
for any adverse effect, including mortality. Other behav-
iors such as body weight, food and water intake, urination,
locomotor activity, hair luster, etc., were also observed
over a period of seven days.
Analgesic activity
Female and male mice were used for the hot plate test
and acetic acid-induced writhing test to evaluate the an-
algesic activities of MNZQ in the central and peripheral
nervous systems, respectively.
Hot plate test
The hot plate test was performed as previously described
[18, 19]. Adult female KM mice (20–25 g) were selected
for this study. The mice were placed on the heated plate
before the experiment. The temperature of the hot plate
was maintained at 55 ± 0.5 °C. The latency between the
placement and shaking or the licking of the hind paws
or the jumping response of the animals was recorded as
the latent response. The mice that exhibited latencies
within 5–30 s were selected for the experiment. The se-
lected mice were divided randomly into five groups of
eight animals each. The pre-treatment reaction time of
each mouse was recorded. The control vehicle (distilled
water, 20 mL/kg, p.o.), ASA positive control (100 mg/kg,
p.o.), and three doses of MNZQ (0.8, 2.4, and 7.2 g/kg,
p.o.) were administered orally for six consecutive days.
On day 7 at 1 h after oral administration, the post-
treatment reaction time of each animal was recorded
after 30, 60, 90, and 120 min [20]. If the pain domain
values exceeded 60 s, then the cut-off time was set to
60 s to avoid scalding of mouse foot. The percentage in-
hibition was calculated by using the following formula:
%Inhibition = [(Post-treatment Latency) − (Pre-treatment
Latency)]/Pre-treatment Latency × 100.
Acetic acid-induced abdominal writhing in mice
The test for the writhing study was performed as previ-
ously described [21]. The mice were randomly divided
into the following five treatment groups of eight animals
each: vehicle control (distilled water, 20 mL/kg, p.o.),
ASA positive control (100 mg/kg, p.o.), and three doses
of MNZQ (0.8, 2.4, and 7.2 g/kg, p.o.). These treatments
were administered orally for six consecutive days. On
day 7 at 1 h after oral administration, the mice were
induced to writhing with 0.6 % acetic acid solution in
normal saline injected intraperitoneally at a dose of
10 mL/kg. The frequencies of writhing (abdominal con-
strictions, pelvic rotation, and hind limb stretching)
were recorded for 15 min, and the first time (recorded
as latent period) writhing appeared after acetic acid in-
jection was also recorded. The percentage analgesic
activity was calculated using the following formula:
%Inhibition = [Numbers of writhes (control) −Numbers
of writhes (test)]/Numbers of writhes (control) × 100.
Anti-inflammatory activity
Xylene-induced ear edema in mice
The acute inflammatory activity of MNZQ was evaluated
using xylene-induced ear edema in mice as previously
described [22, 23]. The mice were randomly divided into
the following five treatment groups of eight animals
each: vehicle control (distilled water, 20 mL/kg, p.o.),
ASA positive control (100 mg/kg, p.o.), and three doses
of MNZQ (0.8, 2.4, and 7.2 g/kg, p.o.). These treatments
were administered orally for six consecutive days. On
day 7 at 1 h after oral administration, 30 μL of xylene was
applied on both surfaces of right ear to induce edema.
The left ear served as a control. The mice were sacrificed
30 min after xylene treatment by performing cervical
dislocation. The right and left ears of the mice were re-
moved with an 8-mm diameter cork borer, and the ears
were weighed. The edema weight difference between the
right and left ears of the same animal was measured. The
percentage of inhibition compared with the control group
was calculated using the following formula: %Inhibition
= [(Weight of edema (control) −Weight of edema (test)]/
Weight of edema (control) × 100.
Carrageenan-induced rat hind paw edema
The test carrageenan-induced rat hind paw edema was
evaluated as previously described [24]. The rats were ran-
domly divided into the following five treatment groups of
eight animals each: vehicle control (distilled water, 10 mL/
kg, p.o.), diclofenac positive control (5 mg/kg, p.o.), and
three doses of MNZQ (0.54, 1.62, and 4.86 g/kg, p.o.).
These treatments were administered orally for six con-
secutive days. On day 7 at 1 h after oral administration,
0.1 mL of 1 % carrageenan in saline was injected into the
plantar area of the rat right hind paw. The hind paw vol-
umes before (0 h) the injection of carrageenan and 1, 2, 3,
and 5 h after the injection of carrageenan were measured
using a plethysmometer (Ugo Basile, Milan, Italy). The
percentage of inhibition compared with the control group
was calculated using the following formula: %Inhibition
= [(Volume of edema (control) −Volume of edema (test)]/
Volume of edema (control) × 100.
Cotton pellet-induced granuloma in rats
The chronic anti-inflammatory activity of MNZQ was
evaluated using cotton pellet-induced granuloma in rats
as previously described [25, 26]. The rats were randomly
divided into the following five treatment groups of eight
animals each. Each rat was anesthetized and shaven, and
two sterilized cotton pellets weighing 20.00 ± 1.00 mg
each were surgically implanted into both sides of the
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groin region of each rat on the first day. The next day
after surgery, the rats underwent intragastric administra-
tion of distilled water, diclofenac, and MNZQ (grouping
the same as that in the test of carrageenan-induced rat
hind paw edema). After 7 d, all of the rats were sacri-
ficed by performing cervical dislocation, and the pellets
surrounded by granuloma tissue were carefully dissected.
The pellets were cleared of surrounding tissues, weighed
to obtain the moist weight. Then the moist pellets were
dried overnight at 60 °C and weighed again to obtain the
dry weight. The differences in moist or dry pellets
weight between the test and control groups were calcu-
lated. The percentage of inhibition compared with the
control group was calculated using the following for-
mula: %Inhibition = [(Weight of pellet (control) −Weight
of pellet (test)]/Weight of pellet (control) × 100.
Statistical analysis
Experimental results were expressed as mean ± standard
error (SEM) with eight animals in each group. Data were
analyzed by one-way ANOVA between different test
groups. SPSS 18.0 was used for all statistical analyses. Re-
sults were considered statistically significant at p < 0.05. All
figures were generated using Graphpad Prism 5 Software.
Results
HPLC fingerprinting and quantitive determination
The results of HPLC fingerprinting of MNZQ were
shown in Fig. 1. Eight characteristic peaks were identi-
fied as chlorogenic acid, caffeic acid, ferulic acid, liquir-
itin, harmaline, harmine, apigenin 7-O-glucoside, and
isoliquiritin. Comparison of the HPLC chromatograms
of individual herbal medicines with standard reference
substances confirmed that liquiritin and isoliquiritin are
from the characteristic compositions of G. uralensis,
harmaline and harmine from P. harmala, chlorogenic acid
from P. anisum, M. chamomilla, and D. moldavica, caffeic
acid from D. moldavica, ferulic acid from F. vulgare, and
apigenin 7-O-glucoside from M. chamomilla and A.
graveolens roots. The contents of chlorogenic acid, caffeic
acid, ferulic acid, liquiritin, harmaline, harmine, apigenin
7-O-glucoside, and isoliquiritin in MNZQ were deter-
mined as 17.29, 4.04, 3.73, 72.14, 270, 120, 2.77, and
10.48 μg/g, respectively.
Analgesic activity
Effects of hot plate
The results of the hot plate test on the analgesic activities
of MNZQ in the central nervous system were shown in
Fig. 2. MNZQ at 2.4 and 7.2 g/kg showed significantly in-
creased analgesic effect in the 30–120 min latency period
after administration. The inhibition percentages of 2.4
and 7.2 g/kg MNZQ increased by 67.54 % and 64.64 %
(p < 0.001) at 30 min after administration, and by
79.79 % (p < 0.01) and 101.47 % (p < 0.001) at 60 min
after administration, respectively. Meanwhile, the inhib-
ition percentages with positive control ASA (100 mg/kg)
increased by 59.64 % and 73.20 % at 30 and 60 min after
administration, respectively. However, MNZQ at 0.8 g/kg
showed no significant analgesic activity at the 30 and
60 min latency periods after administration (p < 0.05). The
inhibition percentages of 0.8, 2.4, and 7.2 g/kg MNZQ
Fig. 1 HPLC fingerprinting of MNZQ (a) and chromatogram of standard references (b) (1. chlorogenic acid, 2. caffeic acid, 3. ferulic acid, 4.
liquiritin, 5. harmaline, 6. harmine, 7. apigenin 7-O-glucoside, and 8. isoliquiritin)
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increased by 59.05 % (p < 0.05), 97.84 % (p < 0.001),
and 95.13 % (p < 0.001) at 90 min after administra-
tion, and by 77.43 % (p < 0.05), 85.47 % (p < 0.05), and
112.38 % (p < 0.001) at 120 min after administration,
respectively. Meanwhile, the inhibition percentages of
the positive control ASA (100 mg/kg) increased by
83.78 % (p < 0.001) and 78.76 % (p < 0.05) at 90 and
120 min after administration, respectively. All differences
were compared with the vehicle control (distilled water).
Effects of acetic acid-induced abdominal writhing in mice
The peripheral analgesic activities of MNZQ on acetic
acid-induced abdominal writhing in mice were shown in
Fig. 3. MNZQ at 0.8, 2.4, and 7.2 g/kg significantly
inhibited the acetic acid-induced writhing response
within 15 min by 25.22 % (p < 0.01), 44.60 % (p < 0.001),
and 49.41 % (p < 0.001), respectively. The positive con-
trol ASA (100 mg/kg) also strongly inhibited the writing
response by 51.20 % (p < 0.001) (Fig. 3a). Compared with
the control treatment, MNZQ at 2.4 and 7.2 g/kg signifi-
cantly delayed the onset period of writhing behavior by
49.15 % and 51.88 % (p < 0.05), respectively. Meanwhile,
the positive control ASA (100 mg/kg) delayed the latent
period by 138.90 % (p < 0.001). However, 0.8 g/kg
MNZQ did not significantly delay the latent period com-
pared with the vehicle control (Fig. 3b).
Anti-inflammatory activity
Effects of xylene-induced ear edema in mice
The dose dependent effects of MNZQ against acute
inflammation in xylene-induce ear edema in mice
were shown in Fig. 4. Compared with the control
treatment, MNZQ at 0.8, 2.4, and 7.2 g/kg decreased
ear edema by 17.18 % (p < 0.05), 22.17 % (p < 0.01),
and 22.24 % (p < 0.01), respectively. The positive control
ASA (100 mg/kg), meanwhile, inhibited ear edema by
25.80 % (p < 0.001).
Effects of carrageenan-induced rat hind paw edema
The effects of MNZQ on acute inflammation in the
carrageenan-induced rat hind paw edema were shown in
Fig. 5. Compared with the control treatment, MNZQ at
1.62 and 4.86 g/kg significantly inhibited rat hind paw
edema by 82.43 % and 84.32 % (p < 0.001), respectively,
at 1 h after administration. MNZQ at 0.54 g/kg did not
significantly inhibit edema. Low-dosage MNZQ took
Fig. 2 Effects of MNZQ on hot plate analgesic test in mice. The time
between the placement of mouse and its shaking or licking of the
hind paws on a hot plate for 30, 60, 90, and 120 min after administration
was recorded as reaction time. Vehicle control mice were administered
with distilled water, and ASA (100 mg/kg) was used as the positive
control. Results are expressed as the mean ± SEM (n= 8) of the reaction
time in seconds. *p < 0.05, **p< 0.01, ***p< 0.001 were considered
significant when compared at the same time with the vehicle control
(distilled water) after administration
Fig. 3 Effect of MNZQ on acetic acid-induced abdominal writhing in mice. Frequency of writhing within 15 min (a) and the latent period (b) after
intraperitoneal injection of acetic acid. Vehicle control mice were administered with distilled water, and ASA (100 mg/kg) was used as the positive
control. Results are expressed as the mean ± SEM (n = 8) of the reaction time in seconds. *p < 0.05, **p < 0.01, ***p < 0.001 were considered
significant when compared with the vehicle control (distilled water) after administration
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effect at 2 h after administration and prolonged to 5 h.
Meanwhile, the positive control diclofenac (5 mg/kg)
significantly decreased carrageenan-induced rat hind
paw edema in a time-dependent manner (until 5 h after
administration).
Effects of cotton pellet-induced granuloma in rats
The effects of MNZQ against chronic inflammation in
cotton pellet-induced granuloma in rats were shown in
Fig. 6. The moist weight of granuloma showed that
MNZQ at 1.62 and 4.86 g/kg significantly inhibited left
side granuloma formation by 8.81 % (p < 0.01) and
19.15 % (p < 0.001) and right side granuloma formation
by 11.37 % (p < 0.001) and 12.84 % (p < 0.001), respect-
ively, compared with the control treatment. In addition,
the dry weight of granuloma reflected that MNZQ at
1.62 and 4.86 g/kg inhibited left side granuloma forma-
tion by 14.84 % (p < 0.05) and 27.40 % (p < 0.001) and
right side granuloma by 17.07 % (p < 0.001) and 17.60 %
(p < 0.001), respectively. Diclofenac (5 mg/kg), positive
control, also significantly inhibited inflammation in both
sides of cotton pellet (p < 0.001).
Discussion
During the period of drug administration for 7 days,
food and water intake, urination, hair luster, locomotor
activity, and behavior of animals in control and three
drug treatment groups indicated no any significance.
As shown in Fig. 7, the rats body weight growth curves
of animals in control and three drug treatment groups
shown similar trend without no significant difference
(p > 0.05), as the experiment ongoing. These observa-
tions indicated that the high dose (4.86 g/kg for rats or
7.2 g/kg for mice) of MNZQ was safe.
Different models of thermal and chemical nociception in
animals were used to evaluate the anti-inflammatory and
analgesic activities of MNZQ. The hot plate test and acetic
acid-induced abdominal writhing test were commonly
used to assess central and peripheral activity models [27].
The two nociception models revealed the analgesic activ-
ities of MNZQ on the central and peripheral nervous
systems. Among the composition of MNZQ, P. harmala
seeds, P. anisum, and D. moldavica possibly contributed
the greatest to the analgesic activities of the medicine. The
seeds of P. harmala as one of the main medicinal plants in
MNZQ, the main active components of P. harmala are
beta-carboline alkaloids harmine and harmaline [28, 29]. It
was reported that the alkaloid extract of P. harmala seeds,
which mainly consists of harmine and harmaline, exerts
anti-inflammatory and analgesic activities [30, 31]. It was
reported that P. anisum, another main herbal component
in MNZQ, can reduce morphine dependence and help
relieve dysmenorrhea and the hot flash symptoms in
menopausal women [32]. D. moldavica extracts also pos-
sess sedative and analgesic activities [33]. It is reported that
the abdominal constriction is related to the sensitization
of nociceptive receptors to prostaglandins [34, 35]. Local
irritation produced by an intraperitoneal injection of
acetic acid triggers the release pro-inflammatory cytokines
such as IL-1, IL-6, IL-8 and TNF-α [36]. The hot plate test
is assessed the participation of opioid, adenosine, and
glutamate receptor systems [37]. These analgesic models
suggested that the analgesic effect of MNZQ may be
mediated by inhibiting the synthesis and release of
Fig. 4 Effect of MNZQ on xylene-induced ear edema in mice. Mice
were administered with MNZQ orally 1 h before xylene (30 μL/ear)
was applied to the right ears of the mice. Vehicle control mice were
administered with distilled water, and ASA (100 mg/kg) was used as
the positive control. Results are expressed as the mean ± SEM (n = 8)
of the percentage inhibition of edema. *p < 0.05, **p < 0.01, ***p < 0.001
were considered significant when compared with the vehicle control
(distilled water) after administration
Fig. 5 Effect of MNZQ on carrageenan-induced rat hind paw edema.
Rats were administered orally with MNZQ 1 h before carrageenan
injection to the right hind paw. Vehicle control mice were administered
with distilled water, and diclofenac (5 mg/kg) was used as the
positive control. Results are expressed as the mean ± SEM (n = 8)
of the percentage inhibition of edema. *p < 0.05, **p < 0.01, ***p < 0.001
were considered significant when compared with the vehicle control
(distilled water) after administration
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prostaglandins and other pro-inflammatory cytokines such
as IL-1, IL-6, IL-8, and TNF-α.
One chronic model and two acute models of inflam-
mations were adopted in the present study to evaluate
the anti-inflammatory effects of MNZQ. The model of
xylene-induced ear edema in mice was linked to neuro-
genous edema release of inflammatory mediators such as
histamine, kinin, and fibrinolysin [38, 39]. Carrageenan-
induced rat hind paw edema model is widely used to
evaluate anti-inflammatory activities [40]. Carageenan-
induced edema is biphasic, the first phase (first 90 min)
after carrageenan injection releases some chemical media-
tors of serotonin, histamine, bradykinin, and similar sub-
stances, whereas the second or late phase (after 90 min) is
linked to the release of prostaglandins, proteases, and
lysosomes [27, 41]. In addition, the late phase is related to
the induction of cyclooxygenase in the hind paw [42].
Chronic inflammation was evaluated using a classic model
of cotton pellet-induced granuloma in rats. The results of
the present study revealed that MNZQ can significantly
inhibit carrageenan-induced rat hind paw edema and
effectively reduce cotton pellet granuloma.
Among the 13 species medicinal plants in MNZQ,
M. chamomilla and Glycyrrhiza have been widely
used to eliminate inflammation for centuries. Main
beta-carboline alkaloids harmine can significantly de-
crease xylene-induced ear edema and carrageenan-
induced rat hind paw edema [43]. It was confirmed
that the mechanism on anti-inflammatory activity of P.
harmala alkaloids is to inhibit myeloperoxidase [31].
There are increasing evidences that flavonoids and phen-
olic acids substance have good anti-inflammatory effects.
The extract of Glycyrrhiza contains a large number of
flavonoids, isoflavonoids, chalcones, and triterpene sapo-
nins, including liquiritin, isoliquiritin, glycyrrhizic acid,
and liquiritigenin, which have been demonstrated poten-
tial anticancer, antiviral, and anti-inflammatory activities
[44, 45]. Given its anti-inflammatory and analgesic proper-
ties, M. chamomilla has been used for centuries as a
medicinal plant. Among the constituents of aqueous M.
chamomilla extract, the main ingredients of apigenin 7-
O-glucoside, apigenin exerts strong anti-inflammatory
activity against pro-inflammatory agents. In rats, apigenin
7-O-glucoside can inhibit skin inflammation caused by
the application of xanthine–oxidase and cumene hydro-
peroxide [45, 46]. Thus, these medicinal plants and their
active components may be responsible for the anti-
inflammatory activity of MNZQ.
The current study confirmed the anti-inflammatory and
analgesic properties of MNZQ through several animal
tests. However, further studies are warranted to elucidate
the exact mechanism of action and confirm the chemical
compounds responsible for the anti-inflammatory and
analgesic effects of MNZQ.
Fig. 6 Effect of MNZQ on cotton pellet-induced granuloma in rats. Weight of moist granuloma (a) and dry granuloma (b). Vehicle control mice
were administered with distilled water; diclofenac (5 mg/kg) was used as the positive control. Results are expressed as the mean ± SEM (n = 8)
of the percentage inhibition of edema. *p < 0.05, **p < 0.01, ***p < 0.001 were considered significant when compared with the vehicle control
(distilled water) after administration
Fig. 7 The body weight growth curves of rats after administration
MNZQ. Vehicle control was administered with distilled water
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Conclusions
MNZQ exhibits significant anti-inflammatory activities
and analgesic effects on the central and peripheral ner-
vous systems. This study provides scientific foundation
for the ethnobotanical uses of MZNQ in alleviating pain
and treating inflammatory disorders.
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